Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Radiation Oncology Physician in Saint Louis, MO
NPI: 1265536635Primary Employer
VA St Louis Health Care System
va.gov
HQ Phone
Get MD, MBA, FACR Jonathan's Phone Numberphone_androidMobile
Get MD, MBA, FACR Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
CT State Medical License
CA State Medical License
GA State Medical License
ME State Medical License
2021 - 2027
NY State Medical License
1983 - 2027
PA State Medical License
2007 - 2024
GA State Medical License
2007 - 2021
CA State Medical License
1988 - 2020
CT State Medical License
2005 - 2019
MD State Medical License
1988 - 1990
American Board of Radiology
Radiation Oncology
Columbia University School of Business
M.B.A. • 1990 - 1993
1990 - 1993
Memorial Sloan Kettering Cancer Center
Residency • Radiation Oncology
1985 - 1988
SUNY Downstate Health Sciences University
downstate.edu
Residency • Surgery
1982 - 1985
MCP-Hahnemann College of Medicine
Medical School
Until 1982
Lehigh University
B.A. • With honors
1975 - 1980
Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma.
Authors: William Mendenhall, Oded Cohen, Ashok Shaha
Journal: Int J Part Ther
Publication Date: 2023-04-27
Authors: Nabil Saba, Andrew Miller
Journal: Psychosom Med
Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer
Authors: Canhua Xiao, Ronald C. Eldridge, Jonathan J. Beitler, Kristin Higgins, Cynthia E Chico, Jennifer C. Felger, Evanthia C. Wommack, Tish Knobf, Nabil F. Saba, Dong M. Shin, Deborah Watkins Bruner, Andrew H. Miller
Publication Date: 2020-06
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, PROCEDURE: Biopsy Procedure, RADIATION: Image Guided Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology, Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Cetuximab, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, BIOLOGICAL: Durvalumab
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, OTHER: Clinical Observation, DRUG: Gemcitabine Hydrochloride, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, DRUG: Fluorouracil, RADIATION: Intensity-Modulated Radiation Therapy